MoneyWorks4Me

Gujarat Themis Biosyn informs about analyst meet

09 Dec 2021 Evaluate

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, Gujarat Themis Biosyn has informed that the management of the Company had a one-on-one conference call with Analysts/Investors on Wednesday, 8th December 2021; the details of the same are enclosed. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..